Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats.
Journal Information
Full Title: Dose Response
Abbreviation: Dose Response
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Radiology, Nuclear Medicine & Medical Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of Conflicting Interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Sergey A. Tarasov, Nataliya V. Petrova and Oleg I. Epstein are employees of OOO “NPF “MATERIA MEDICA HOLDING” (partly). Oleg I. Epstein is a founder and a shareholder of OOO “NPF “MATERIA MEDICA HOLDING. OOO “NPF “MATERIA MEDICA HOLDING” sponsored the study, performed statistical analysis, made a decision to publish the work, and covered the current article processing charges, took part in the design of the experiments and the manuscript writing. HD Abs to eNOS is the substance (single, or one among other components) for commercial drugs Impaza, Divaza, Subetta, Afalaza produced by OOO “NPF “MATERIA MEDICA HOLDING”. Patents on this substance and the drugs belong either to OOO “NPF “MATERIA MEDICA HOLDING”, or Oleg I. Epstein. The authors have disclosed those interests fully to Dose-Response Journal."
"Funding: OOO “NPF “MATERIA MEDICA HOLDING” sponsored the study."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025